Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Felzartamab |
| Trade Name | |
| Synonyms | MOR03087|TJ202|MOR202 |
| Drug Descriptions |
Felzartamab (MOR202) is a monoclonal antibody that binds CD38, potentially resulting in increased cytoxicity against CD38-expressing tumor cells and tumor cell lysis (PMID: 29654274, PMID: 32171061). |
| DrugClasses | CD38 Antibody 21 |
| CAS Registry Number | NA |
| NCIT ID | C97954 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Dexamethasone + Felzartamab | Dexamethasone Felzartamab | 0 | 0 |
| Dexamethasone + Felzartamab + Lenalidomide | Dexamethasone Felzartamab Lenalidomide | 0 | 0 |
| Dexamethasone + Felzartamab + Pomalidomide | Dexamethasone Felzartamab Pomalidomide | 0 | 0 |
| Felzartamab | Felzartamab | 0 | 0 |
| Felzartamab + Lenalidomide | Felzartamab Lenalidomide | 0 | 0 |
| Felzartamab + Lenalidomide + Vitamin D | Felzartamab Lenalidomide Vitamin D | 0 | 0 |